The Korean journal of internal medicine

  • 제27권1호
  • /
  • Pages.39-40
  • /
  • 2012
  • /
  • 1226-3303(pISSN)
  • /
  • 2005-6648(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지
DOI QR코드

DOI QR Code

An Emerging Diabetes Mellitus Diagnosis Modality: $HbA_{1c}$

  • Seo, Hyun-Ae (Department of Internal Medicine, Kyungpook National University School of Medicine) ;
  • Lee, In-Kyu (Department of Internal Medicine, Kyungpook National University School of Medicine)
  • 발행 : 2012.03.01
⟨ 이전 논문 다음 논문 ⟩

초록

키워드

참고문헌

  1. Ollerton RL, Playle R, Ahmed K, Dunstan FD, Luzio SD, Owens DR. Day-to-day variability of fasting plasma glucose in newly diagnosed type 2 diabetic subjects. Diabetes Care 1999;22:394-398. https://doi.org/10.2337/diacare.22.3.394
  2. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-412. https://doi.org/10.1136/bmj.321.7258.405
  3. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 1995;44:968-983. https://doi.org/10.2337/diabetes.44.8.968
  4. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327-1334. https://doi.org/10.2337/dc09-9033
  5. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33 Suppl 1:S62-S69. https://doi.org/10.2337/dc10-S062
  6. Sabanayagam C, Liew G, Tai ES, et al. Relationship between glycated haemoglobin and microvascular complications: is there a natural cut-off point for the diagnosis of diabetes? Diabetologia 2009;52:1279-1289. https://doi.org/10.1007/s00125-009-1360-5
  7. Kirk JK, Bell RA, Bertoni AG, et al. Ethnic disparities: control of glycemia, blood pressure, and LDL cholesterol among US adults with type 2 diabetes. Ann Pharmacother 2005;39:1489-1501. https://doi.org/10.1345/aph.1E685
  8. Herman WH, Ma Y, Uwaifo G, et al. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care 2007;30:2453-2457. https://doi.org/10.2337/dc06-2003
  9. Yu Y, Ouyang XJ, Lou QL, et al. Validity of glycated hemoglobin in screening and diagnosing type 2 diabetes mellitus in Chinese. Korean J Intern Med 2012;27:41-46. https://doi.org/10.3904/kjim.2012.27.1.41
  10. Yun WJ, Shin MH, Kweon SS, et al. A comparison of fasting glucose and HbA1c for the diagnosis of diabetes mellitus among Korean adults. J Prev Med Public Health 2010;43:451-454. https://doi.org/10.3961/jpmph.2010.43.5.451
  11. Korean Diabetes Association. Treatment Guideline for Diabetes. Seoul: Korean Diabetes Association, 2011.
  12. Malkani S, Mordes JP. Implications of using hemoglobin A1C for diagnosing diabetes mellitus. Am J Med 2011;124:395-401. https://doi.org/10.1016/j.amjmed.2010.11.025

피인용 문헌

  1. Evaluation of Glycated Hemoglobin (HbA1c) for Diagnosing Type 2 Diabetes and Prediabetes among Palestinian Arab Population vol.9, pp.2, 2014, https://doi.org/10.1371/journal.pone.0088123